Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers

EMBO Journal

Volumn 17, Issue 12, 1998, Pages 3385-3397

  Lenferink, Anne E G ^a   Pinkas Kramarski, Ronit ^b   Van De Poll, Monique L M ^a   Van Vugt, Marianne J H ^a   Klapper, Leah N ^b   Tzahar, Eldad ^b   Waterman, Hadassa ^b   Sela, Michael ^b   Van Zoelen, Everardus J J ^a   Yarden, Yosef ^b  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Endocytosis; ErbB; HER family; Oncogene; Signal transduction; Transforming growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALS; DIMERIZATION; ENDOCYTOSIS; EPIDERMAL GROWTH FACTOR; HUMANS; MICE; ONCOGENE PROTEINS V-ERBB; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0032526729     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.12.3385     Document Type: Article

References (81)

1. Alimandi, M., Romano, A., Curia, M.C., Muraro, R., Fedi, P., Aaronson, S.A., Di Fiore, P.P. and Kraus, M.H. (1995) Cooperative signaling of ErbB-3 and ErbB-2 in neoplastic transformation of human mammary carcinoma cells. Oncogene, 15, 1813-1821.
2. Alroy, I. and Yarden, Y. (1997) The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett., 410, 83-86.
3. Bargmann, C.I., Hung, M.C. and Weinberg, R.A. (1986) Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell, 45, 649-657.
4. Barrandon, Y. and Green, H. (1987) Cell migration is essential for sustained growth of keratinocyte colonies: the roles of transforming growth factor-α and epidermal growth factor. Cell, 50, 1131-1137.
5. Basu, S.K., Goldstein, J.L., Anderson, R.G.W. and Brown, M.S. (1981) Monensin interrupts the recycling of low density lipoprotein receptors in human fibroblasts. Cell, 24, 493-502.
6. Baulida, J., Kraus, M.H., Alimandi, M., Di Fiore, P.P. and Carpenter, G. (1996) All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J. Biol. Chem., 271, 5251-5257.
7. Beerli, R.R. and Hynes, N.E. (1996) Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J. Biol. Chem., 271, 6071-6076.
8. Ben-Levy, R., Paterson, H.E. Marshall, C.J. and Yarden, Y. (1994) A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP-kinase pathway. EMBO J., 13, 3302-3311.
9. Burden, S. and Yarden, Y. (1997) Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis. Neuron, 18, 847-855.
10. Cardelli, J.A., Richardson, J. and Meiars, D. (1989) Role of acidic intracellular compartment in the biosynthesis of dictiostelium lysosomal enzymes. J. Biol. Chem., 264, 3454-3464.
11. Carraway, K.L. and Cantley, L.C. (1994) A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling. Cell, 78, 5-8.
12. Carver, R.S., Sliwkowski, M.X., Sitaric, S. and Russell, W.E. (1996) Insulin regulates heregulin binding and ErbB3 expression in rat hepatocytes. J. Biol. Chem., 271, 13491-13496.
13. Cohen, B.D., Kiener, P.K., Green, J.M., Foy, L., Fell, H.P. and Zhang, K. (1996) The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH-3T3 cells. J. Biol. Chem., 271, 30897-30903.
14. Di Fiore, P.P., Pierce, J.H., Kraus, M.H., Segatto, O., King, C.R. and Aaronson, S.A. (1987) erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science, 237, 178-182.
15. Eagan, S.E. and Weinberg, R.A. (1993) The pathway to signal achievement. Nature, 365, 781-783.
16. Ebner, R. and Derynck, R. (1991) Epidermal growth factor and transforming growth factor-α: differential intracellular routing and processing of ligand-receptor complexes. Cell Regul., 2, 599-612.
17. Felder, S., Miller, K., Moehren, G., Ullrich, A., Schlessinger, J. and Hopkins, C.R. (1990) Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body. Cell, 61, 623-634.
18. Gladhaug, I.P. and Christofferson, T. (1988) Rapid constitutive internalization and externalization of epidermal growth factor receptors in isolated rat hepatocytes. J. Biol. Chem., 263, 12199-12203.
19. Glenney, J.R., Chen, W.S., Lazar, C.S., Walton, G.M., Zokas, L.M., Rosenfeld, M.G. and Gill, G.N. (1988) Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies. Cell, 52, 675-684.
20. Graus-Porta, D., Beerly, R., Daly, J.M. and Hynes, N.E. (1997) ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J., 16, 1647-1655.
21. Greenberger, J.S., Sakakeeny, M.A., Humphries, R.K., Eaves, C.J. and Eckner, R.J. (1983) Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc. Natl Acad. Sci. USA, 80, 2931-2935.
22. Gulliford, T.J., Huang, G.C., Ouyang, X. and Epstein, E.J. (1997) Reduced ability of transforming growth factor-α to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2. Oncogene, 15, 2219-2223.
23. Guren, T.K., Thoresen, G.H., Dajani, O.F., Taraldsrud, E., Moberg, E.R. and Christoffersen, T. (1996) Epidermal growth factor behaves as a partial agonist in hepatocytes: effects on DNA synthesis in primary culture and competition with transforming growth factor α. Growth Factors, 13, 171-179.
24. Guy, P.M. Platko, J.V., Cantley, L.C. Cerione, R.A. and Carraway, K.L. (1994) Insect cell-expressed p180ErbB3 possesses an impaired tyrosine kinase activity. Proc. Natl Acad. Sci. USA, 91, 8132-8136.
25. Hamel, F.G., Siford, G.L., Jones, J. and Duckworth, W.C. (1997) Intraendosomal degradation of transforming growth factor α. Mol. Cell. Endocrinol., 126, 185-192.
26. Honegger, A.M., Dull, T.J., Bellot, F., Van Obbergghen, E., Szapary, D., Schmidt, A., Ullrich, A. and Schlessinger, J. (1988) Biological activities of EGF receptor mutants with individually altered autophosphorylation sites. EMBO J., 7, 3045-3052.
27. Hudziak, R.M. Schlessinger, J. and Ullrich, A. (1987) Increased expression of the putative growth factor receptor p185HER-2 causes transformation and tumorigenesis of NIH-3T3. Proc. Natl Acad. Sci. USA, 84, 7159-7163.
28. Hynes, N.E. and Stern, D.F. (1994) The biology of erbB-2/neu/HER-2 and its role in cancer. Biochem. Biophys. Acta, 1198, 165-184.
29. Karasuyama, H. and Melchers, F. (1988) Establishment of mouse cell lines that constitutively secrete large quantities of interleukins 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol., 18, 97-104.
30. Karunagaran, D., Tzahar, E., Beerli, R.R., Chen, X., Graus-Porta, D., Ratzkin, B.J., Seger, R., Hynes, N.E. and Yarden, Y. (1996) ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J., 15, 254-264.
31. Kim, H.-H., Sierke, S.L. and Koland, J.G. (1994) Epidermal growth factor-dependent association of phosphatidylinositol 3′-kinase with the erbB-3 gene product. J. Biol. Chem., 269, 24747-24755.
32. Klapper, L.N., Vaisman, N., Hurwitz, E., Pinkas-Kramarski, R., Yarden, Y. and Sela, M. (1997) A subclass of tumor-inhibitory monoclonal antibodies to erbB-2/HER2 blocks crosstalk with growth factor receptors. Oncogene, 14, 2099-2109.
33. Koch, A.C. Anderson, D., Moran, M.F., Ellis, C. and Pawson, T. (1991) SH-2 and SH-3 domains: Elements that control interactions of cytoplasmic signaling proteins. Science, 252, 668-674.
34. Kokai, Y. Myers, J.N., Wada, T., Brown, V.I., LeVea, C.M., Davis, J.G., Dobashi, K. and Greene, M.I. (1989) Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell 58, 287-292.
35. Korc, M. and Finman, J.E. (1989) Attenuated processing of epidermal growth factor in the face of marked degradation of transforming growth factor α. J. Biol. Chem., 264, 14990-14999.
36. Kornfeld, K. (1997) Vulval development in Caenorhabditis elegans. Trends Genet., 13, 55-61.
37. Kramer, R.H., Leferink, A.E.G., van Buern-Koornneef, I.L., van der Meer, A., van de Poll, M.L.M. and van Zoelen, E.J.J. (1994) Identification of the high affinity binding site of transforming growth factor-α (TGF-α) for the chicken epidermal growth factor (EGF) receptor using EGF/TGF-α chimeras. J. Biol. Chem., 269, 8708-8711.
38. Lee, K.F., Simon, H., Chen, H., Bates, B., Hung, M.C. and Hauser, C. (1995) Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature, 378, 394-398.
39. Lenferink, A.E.G., Kramer, R.H., van Vugt, M.J.H., Konigswieser, M., di-Fiore, P.P., van Zoelen, E.J.J. and van de Poll, L.M.L. (1997) Superagonistic behaviour of epidermal growth factor/transforming growth factor-α chimeras: correlation with receptor routing after ligand-induced internalization. Biochem. J., 327, 859-865.
40. Levkowitz, G., Klapper, L.N., Tzahar, E., Freywald, A., Sela, M. and Yarden, Y. (1996) Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins. Oncogene, 12, 1117-1125.
41. Lipeski, L.E., Boylan, J.M. and Gruppuso, P.A. (1996) A comparison of epidermal growth factor receptor-mediated mitogenic signaling in response to transforming growth factor α and epidermal growth factor in cultured fetal rat hepatocytes. Biochem. Mol. Biol. Int., 39, 975-983.
42. Lonardo, F., Di Marco, E., King, C.R., Pierce, J.H., Segatto, O., Aaronson, S.A. and Di Fiore, P.P. (1990) The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand. New Biol., 2, 992-1003.
43. Marshall, C.J. (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell, 80, 179-185.
44. Mayes, E.L.V. and Waterfield, M.D. (1984) Biosynthesis of the epidermal growth factor receptor in A431 cels. EMBO J., 3, 531-537.
45. Ming, X.-F., Buegering, B.M.T., Wensrom, S., Cleasson-Welsh, L., Heldin, C.-H., Bos, J.L., Kozma, S.C. and Thomas, G. (1994) Activation of the p70/p85 S6-kinase by a pathway independent of p21ras. Nature, 371, 426-429.
46. Mosman, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63.
47. Nilson, B. and Abrahmsen, L. (1990) Fusions of Staphylococal protein A. Methods Enymol., 185, 144-161.
48. Peles, E., Ben-Levy, R., Tzahar, E., Liu, N., Wen, D. and Yarden, Y. (1993) Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships. EMBO J., 12, 961-971.
49. Pinkas-Kramarski, R., Soussan, L., Waterman, H., Levkowitz, G., Alroy, I., Klapper, L., Lavi, S., Seger, R., Ratzkin, B., Sela, M. and Yarden, Y. (1996a) Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J., 15, 2452-2467.
50. Pinkas-Kramarski, R., Shelly, M., Glathe, S., Ratzkin, B.J. and Yarden, Y. (1996b) Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations. J. Biol. Chem., 271, 19029-19032.
51. Puddicombe, S.M., Wood, L., Chamberlin, S.G. and Davies, D. (1996) The interaction of an epidermal growth factor/transforming growth factor α tail chimera with the human epidermal growth factor receptor reveals unexpected complexities. J. Biol. Chem., 271, 30392-30397.
52. Reddy, C.C., Niyogi, S.K., Wells, A., Wiley, H.S. and Lauffenburger, D.A. (1996a) Engineering epidermal growth factor for enhanced mitogenic potency. Nature Biotech., 14, 1696-1699.
53. Reddy, C.C., Wells, A. and Laffenburger, D.A. (1996b) Receptor-mediated effects of ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor α. J. Cell. Physiol., 166, 512-522.
54. Renfrew, C.A. and Hubbard, A.L. (1991) Sequential processing of epidermal growth factor in early and late endosomes of rat liver. J. Biol. Chem., 266, 4348-4356.
55. Riese, D.J., van Raaij, T.M. Plowman, G.D., Andrews, G.C. and Stern, D.F. (1995) The cellular response to neuregulins is governed by complex interactions of the ErbB receptor family. Mol. Cell Biol., 15, 5770-5776.
56. Riese, D.J., Kim, E.D., Elenius, K., Buckley, S., Klagsbrun, M., Plowman, G.D. and Stern, D.F. (1996) The epidermal growth factor receptor couples transforming growth factor-α, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4. J. Biol. Chem., 271, 20047-20052.
57. Salomon, D.S., Brandt, R., Ciardiello, F. and Normanno, N. (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol., 19, 183-232.
58. Schreiber, A.B., Winkler, M.E. and Derynck, R. (1986) Transforming growth factor α: more potent angiogenic mediator than epidermal growth factor. Science, 232, 1250-1253.
59. Seger, R. and Krebs, E.G. (1995) The MAP kinase signaling cascade. FASEB J., 9, 726-735.
60. Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A. and McGuire, W.L. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-182.
61. Slamon, D.J., Godolphin, W., Jones, L.A., Holt, J.A., Wong, S.G., Keith, D.E., Levin, W.J., Stuart, S.G., Udove, J., Ullrich, A. and Press, M.F. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712.
62. Soltoff, S.P., Carraway, K.L., Prigent, S.A., Gullick, W.G. and Cantley, L.C. (1994) ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol. Cell Biol., 14, 3550-3558.
63. Sorkin, A. and Waters, C.M. (1993) Endocytosis of growth factor receptors. BioEssays, 15, 375-382.
64. Sorkin, A., Di Fiore, P.P. and Carpenter, G. (1993) The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimera is internalization impaired. Oncogene, 8, 3021-3028.
65. Stancovski, I., Sela, M. and Yarden, Y. (1994) Molecular and clinical aspects of the Neu/ErbB-2 receptor tyrosine kinase. Cancer Treat. Res., 71, 161-191.
66. Strauch, K.L., Johnson, K. and Beckwith, J. (1989) Characterization of degP, a gene required for proteolysis in the cell envelope and for growth of Escherichia coli at high temperature. J. Bacteriol., 171, 2689-2696.
67. Tzahar, E. and Yarden, Y. (1998) The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands. BBA Rev. Cancer, 1377, M25-M37.
68. Tzahar, E., Levkowitz, G., Karunagaran, D., Yi, L., Peles, E., Lavi, S., Chang, D., Liu, N., Yayon, A., Wen, D. and Yarden, Y. (1994) ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms. J. Biol. Chem., 269, 25226-25233.
69. Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B.J. and Yarden, Y. (1996) A hierarchical network of inter-receptor interactions determines signal transduction by NDF/neuregulin and EGF. Mol. Cell Biol., 16, 5276-5287.
70. Tzahar, E., Pinkas-Kramarski, R., Moyer, J., Klapper, L.N., Alroy, I., Levkowitz, G., Shelly, M., Henis, S., Eisenstein, M., Ratzkin, B.J., Sela, M., Andrews, G.C. and Yarden, Y. (1997) Bivalency of EGF-like ligands drives the ErbB signaling network. EMBO J., 16, 4938-1950.
71. van de Poll, M.L.M., Lenferink, A.E.G., van Vugt, M.J.H., Jacobs, J.J.L., Janssen, J.W.H., Joldersma, M. and van Zoelen, E.J.J. (1995) A single amino acid exchange. Arg-45 to Ala, generates an epidermal growth factor (EGF) mutant with hjgh affinity for the chicken EGF receptor. J. Biol. Chem., 270, 22337-22343.
72. van der Geer, P., Hunter, T. and Lindberg, R.A. (1994) Receptor protein-tyrosine kinases and their signal transduction pathways. Ann. Rev. Cell Biol., 10, 251-337.
73. van Zoelen, E.J.J., van Oostwaard, T.M.J. and de Laat, S.W. (1986) Transforming growth factor-β and retinoic aid modulate phenotypic transformation of normal rat kidney cells by epidermal growth factor and platelet-derived growth factor. J. Biol. Chem., 261, 5003-5009.
74. van Zoelen, E.J.J., Kramer, R.H., van Reen, M.M.M., Veerkamp, J.A. and Ross, H.A. (1993) An exact analysis of ligand displacement and saturation curves. Biochemistry, 32, 6275-6280.
75. Walker, F., Nice, E., Fabri, L., Moy, F.J., Liu, J.-F., Wu, R., Scheraga, H.A. and Burgess, A.W. (1990) Resistance to receptor-mediated degradation of a murine epidermal growth factor analogue (EGF-Val-47) potentiates its mitogenic activity. Biochemistry, 29, 10635-10640.
76. Wallasch, C. Weiss, F.U., Niederfellner, G., Jallal, B., Issing, W. and Ullrich, A. (1995) Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J., 14, 4267-4275.
77. Waterman, H., Sabanai, I., Geiger, B. and Yarden, Y. (1998) Alternative intracellular routing of ErbB receptors may determine signaling potency. J. Biol. Chem., 273, 13819-13827.
78. Weiner, D.B., Liu, J., Cohen, J.A., Williams, W.V. and Greene, M.I. (1989) A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature, 339, 230-231.
79. Wells, A., Welsh, J.B., Lazar, C.S., Wiley, H.S., Gill, G.N. and Rosenfeld, M.G. (1990) Ligand-induced transformation by a non-internalizing epidermal growth factor receptor. Science, 247, 962-964.
80. Worthylake, R. and Wiley, H.S. (1997) Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2/neu. J. Biol. Chem., 272, 8594-8601.
81. Zhang, K., Sun, J., Liu, N., Wen, D., Chang, D., Thomason, A. and Yoshinaga, S.K. (1996) Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J. Biol. Chem., 271, 3884-3890.